Amedisys Inc

Historical 13F Holders

Symbol
AMED
CUSIP
023436108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 023436108 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Goldman Sachs Group Inc 13G/A
0% 11/14/2025
Event 9/30/2025
Pentwater Capital Management LP 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $101.00
2026 Q1 1 1.00 $101.00
2025 Q4 1 1.00 $101.00
2025 Q3 4 582 $57.6 k
2025 Q2 349 32.7 M $3.22 B
2025 Q1 330 32.6 M $3.02 B
2024 Q4 328 33.0 M $2.98 B
2024 Q3 304 31.7 M $3.04 B
2024 Q2 311 31.3 M $2.88 B
2024 Q1 309 31.6 M $2.91 B
2023 Q4 314 32.1 M $3.05 B
2023 Q3 309 30.1 M $2.81 B
2023 Q2 319 30.0 M $2.74 B
2023 Q1 291 31.3 M $2.30 B
2022 Q4 292 32.0 M $2.67 B
2022 Q3 302 31.7 M $3.07 B
2022 Q2 305 32.0 M $3.27 B
2022 Q1 350 30.3 M $5.22 B
2021 Q4 344 29.3 M $4.74 B
2021 Q3 369 28.4 M $4.24 B
2021 Q2 391 29.2 M $7.15 B
2021 Q1 411 28.5 M $7.55 B
2020 Q4 423 29.6 M $8.67 B
2020 Q3 418 28.9 M $6.83 B
2020 Q2 376 29.9 M $5.94 B
2020 Q1 353 29.3 M $5.38 B
2019 Q4 343 29.6 M $4.94 B
2019 Q3 301 29.9 M $3.91 B
2019 Q2 314 29.4 M $3.56 B
2019 Q1 334 28.5 M $3.51 B
2018 Q4 318 29.8 M $3.49 B
2018 Q3 289 31.3 M $3.91 B
2018 Q2 229 30.7 M $2.62 B
2018 Q1 204 33.2 M $2.00 B
2017 Q4 196 33.1 M $1.74 B
2017 Q3 173 32.5 M $1.82 B
2017 Q2 179 33.0 M $2.08 B
2017 Q1 162 33.3 M $1.70 B
2016 Q4 174 32.7 M $1.39 B
2016 Q3 166 31.7 M $1.50 B
2016 Q2 177 31.0 M $1.57 B
2016 Q1 177 30.5 M $1.48 B
2015 Q4 177 30.5 M $1.20 B
2015 Q3 183 30.3 M $1.15 B
2015 Q2 153 29.4 M $1.17 B
2015 Q1 141 28.3 M $759 M
2014 Q4 151 29.0 M $852 M
2014 Q3 136 30.1 M $606 M
2014 Q2 131 31.2 M $523 M
2014 Q1 129 30.3 M $451 M